Bharat Biotech is likely to begin Covaxin trial on children by early March 2021. Phase 1 trials will be conducted at a children’s hospital in Nagpur, Maharashtra.
The trial will be undertaken on children aged between 2 and 12 and teenagers, the Times of India cited sources as saying. However, the testing will be conducted in age slabs like 2 to 5 years, 6 to 2 years and 12 to 18 years.
“It will be the first such trial in the world in which paediatric population right from toddlers to teens will be tested for the COVID-19 vaccine,” said Dr Ashish Tajne, the coordinator for such trials.
